pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
pharmadog news

Browse

1,114 stories matching this filter · ← front page

★ save view↓export CSV
rangeto
sort
recentoldestsourcealpha
source
STAT824Endpoints620BioPharma Dive237onclive165Fierce Biotech90BioSpace87raps32globenewswire health26
therapy area
allOncology81Cardiology27Psychiatry & CNS21Vaccines17Immunology17Rare Disease12Hepatology
  • STAT+: AIDS activists slam Biden R&D deal with Gilead over HIV prevention drug patents
    A group of AIDS activists obtained an R&D pact at the heart of a settlement between the U.S. government and Gilead Sciences over patents for HIV prevention.
    STAT · 16d ago↗ source
  • Freenome colorectal cancer test data improve on earlier results
    The new study results could make Abbott, which has an agreement with Freenome to market the blood-based test, the dominant player in colorectal cancer screening, Evercore ISI analysts said.
    BioPharma Dive · 16d ago↗ source
  • STAT+: Dementia study replicates promising outcomes following risk-reduction strategies
    A dementia prevention trial praised as a "landmark" effort further demonstrated the promise of structured programs tailored to local cultures.
← prev
page 12 of 45
next →
fda press21
fda recalls20
fda medwatch17
6
Hematology6
Pulmonology5
Infectious Disease4
Ophthalmology3
Dermatology2
STAT · 16d ago
↗ source
  • Q32 bounces back to claim study success for alopecia drug
    Nearly two years after clinical setbacks cratered Q32’s stock price, new results showed hair growth improvements that surpassed investors’ expectations.
    BioPharma Dive · 16d ago↗ source
  • Agenus surges on study pivot; Apnimed lines up an IPO
    Agenus is financially abandoning an ongoing study in late-line colorectal cancer. Elsewhere, an ebola vaccine began human testing and an important Bristol Myers medicine got an FDA decision date.
    BioPharma Dive · 16d ago↗ source
  • STAT+: UnitedHealth’s questionable review, and more MA stars lawsuits
    UnitedHealth touts a new home care audit, and more health insurers sue CMS over Medicare Advantage quality ratings.
    STAT · 16d ago↗ source
  • Martha Lillard, last U.S. polio patient using iron lung, dies at 78 in Oklahoma
    Martha Lillard, last U.S. polio patient using iron lung, has died at 78 in Oklahoma.
    STAT · 17d ago↗ source
  • STAT+: All eyes on data on Biogen’s tau therapy
    The year of daraxonrasib, a wearable for a myeloma drug, and more biotech news from The Readout
    STAT · 17d ago↗ source
  • STAT+: Pharmalittle: We’re reading about an RFK Jr. push against psychiatric meds, a Sanofi blood cancer drug, and more
    U.S. health secretary Robert F. Kennedy Jr. is pressing forward with his effort to help Americans stop taking SSRI antidepressants
    STAT · 17d ago↗ source
  • Caregivers brace for pay cuts, and maybe homelessness
    A game-changer in pancreatic cancer, a vaccine skeptical HHS nom, and more health news from Morning Rounds
    STAT · 17d ago↗ source
  • Biotech startup funding gap widens despite rebound in VC investment
    Though funding totals represented the highest first-half sum since the start of 2022, industry watchers are concerned that small startups are being left behind.
    BioPharma Dive · 17d ago↗ source
  • Opinion: The shortage of forensic pathologists is hurting justice, public health, and families
    It’s time to solve the case of the missing pathologist.
    STAT · 17d ago↗ source
  • Opinion: Is there a doctor on board? Yes, and airlines depend on it
    Physicians who volunteer on flights assume responsibility with no patient history, limited equipment, and an audience of 200 people.
    STAT · 17d ago↗ source
  • STAT+: A breakthrough in pancreatic cancer has experts excited — and braced for what’s to come
    Pancreatic cancer specialists are excited about the biggest breakthrough in the field in decades. They are also looking around the corner to what comes next.
    STAT · 17d ago↗ source
  • As states absorb Medicaid funding cuts, family caregivers face financial ruin
    Family caregivers of people with disabilities face a grim financial future as several states consider steep cuts to their wages.
    STAT · 17d ago↗ source
  • STAT+: HHS presses ahead with effort to curb antidepressant use
    In a private meeting, HHS officials met with mental health professionals to work on guidance for stopping SSRIs.
    STAT · 17d ago↗ source
  • STAT+: Tau in the spotlight at Alzheimer’s conference
    From STAT's AAIC in 30 newsletter: Researchers focus on tau, and progress on crossing the blood-brain barrier.
    STAT · 17d ago↗ source
  • Nominee for key federal health role has a history of questioning vaccines
    Sean Kaufman's views on vaccines may put him at odds with Sen. Bill Cassidy during next week's confirmation hearing.
    STAT · 19d ago↗ source
  • GSK, Hansoh ADC extends survival in lung cancer study
    GSK claimed the result was a first for an ADC aimed at the “B7-H3” protein, an increasingly popular target of late among cancer drugmakers.
    BioPharma Dive · 19d ago↗ source
  • STAT+: Roche ends Huntington’s gene-silencing programs
    ARPA-H launches bespoke gene therapy push, Lilly and Novo to promote Bridge program, and more biotech news from The Readout
    STAT · 20d ago↗ source
  • STAT+: Pharmalittle: We’re reading about bigger drug discounts in Germany, drugmakers embracing secrecy, and more
    German lawmakers passed a bill that would more than double the discount on branded medicines drugmakers must provide the government
    STAT · 20d ago↗ source
  • FDA Proposes Rule to Modernize Drug Manufacturing Registration
    The U.S. Food and Drug Administration today issued a proposed rule that, if finalized, would create a streamlined registration pathway for distributed manufacturing establishments that operate as a…
    fda press · 20d ago↗ source
  • ARPA-H puts $160M into bespoke drug therapies; Biohaven switches up scientific leadership
    The ARPA-H program could provide researchers with a roadmap to develop personalized gene editing drugs. Elsewhere, a Botox rival succeeded against migraines and two deals were struck.
    BioPharma Dive · 20d ago↗ source
  • FDA quietly pushes back deadline on electric shock ban
    Massachusetts' biggest nursing strike ever, tackling the male loneliness epidemic, and other health news for Morning Rounds
    STAT · 20d ago↗ source
  • Opinion: The primary care crisis paradox
    “Solving the health crisis in the United States will require confronting things far harder than readjusting a fee schedule.”
    STAT · 20d ago↗ source